ADMA Biologics Inc (ADMA) Social Stream



ADMA Biologics Inc (ADMA): $3.67

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ADMA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

ADMA BIOLOGICS INC (ADMA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ADMA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 5 $10 $3 $5.7 $3.67 55.31%
2021-11-11 5 $10 $3 $5.7 $3.67 55.31%
2022-01-06 4 $10.001 $3 $5.7 $3.67 55.31%
2022-03-24 4 $8 $3 $5.3 $3.67 44.41%
2022-03-28 3 $8 $3 $5.3 $3.67 44.41%
2022-05-12 2 $6 $3 $4.625 $3.67 26.02%
2022-07-25 3 $5 $4 $4.5 $3.67 22.62%
2022-08-11 3 $5 $4 $4.666 $3.67 27.14%
2022-10-13 4 $5 $4 $4.75 $3.67 29.43%
2022-11-11 3 $6 $4 $5 $3.67 36.24%
2022-12-12 4 $6 $4 $5 $3.67 36.24%
2023-01-18 4 $6 $4.5 $5.125 $3.67 39.65%

The Trend in the Analyst Price Target


ADMA's average price target has moved down $4.7 over the prior 32 months.

Over the past 43 weeks, ADMA's average upside potential has been 119.64%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-24 4 8 3 5.300 1.50 253.33%
2022-03-28 2 8 3 5.300 1.76 201.14%
2022-08-11 3 5 4 4.666 2.23 109.24%
2022-11-11 3 6 4 5.000 3.27 52.91%
2022-12-12 4 6 4 5.000 3.65 36.99%

ADMA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 44 weeks, ADMA's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ADMA BIOLOGICS INC fares relative to all US stocks, note that its average analyst price target is higher than 41.04% of that group.
  • ADMA has a higher number of analysts covering the stock than 143.2% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ADMA BIOLOGICS INC's variance in analysts' estimates is lower than -351.95% of them.
  • ADMA has a greater upside potential (average analyst target price relative to current price) than 275.64% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, CRDF, BCLI, and CRIS are the three stocks most similar to ADMA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ADMA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6557 seconds.